Drug intelligence / Profile preview

guanosine-2',3'-O-methylidenephosphonate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

Guanosine-2',3'-O-methylidenephosphonate is a synthetic analog of guanosine, in which the 2' and 3' hydroxyl groups of the ribose moiety are protected as a methylidene acetal and the phosphate group is replaced by a phosphonate. This compound is structurally related to other guanosine derivatives such as guanosine-2',3'-O-ethylidenephosphonate, which has been studied as an experimental inhibitor of purine nucleoside phosphorylase. The methylidene modification may confer increased stability against enzymatic degradation compared to natural nucleotides or their simple esters. Its mechanism of action would be expected to involve interference with enzymes that process guanosine or its phosphorylated forms, potentially acting as an inhibitor or substrate mimic for nucleotide-processing enzymes.

02

Targets

PNP (Purine nucleoside phosphorylase)

Beyond the preview

Go deeper on guanosine-2',3'-O-methylidenephosphonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on guanosine-2',3'-O-methylidenephosphonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call